Alcon Inc

0A0D.L | Healthcare | LSE
$62.65
-2.67 (-4.09%)

Key Metrics

Market Cap
$30.81B
P/E Ratio
96.38
EPS
$0.65
Beta
N/A
Dividend Yield
N/A
ROE
4.93%
Current Ratio
2.60

Company Information

Industry
Medical Instruments Supplies

About Alcon Inc

Alcon Inc an eye care company researches develops manufactures distributes and sells eye care products for eye care professionals and their patients worldwide The companys Surgical segment offers equipment instrumentation and diagnostics intraocular lenses IOLs and other implantables and consumables including viscoelastics surgical solutions incisional instruments surgical custom packs and other products for use in surgical procedures Its cataract products include centurion vision system LenSx femtosecond laser LuxOR surgical ophthalmic microscope NGENUITY 3D visualization system and ORA system for intraoperative measurements custom pak surgical procedure packs vitreoretinal products comprising constellation vision systems procedure packs lasers and handheld microsurgical instruments and grieshaber and MIVS instruments as well as scissors forceps and microinstruments medical grade vitreous tamponades and Hypervit vitrectomy probes refractive surgery products including WaveLight lasers and Contoura Vision used for LASIK treatment EXPRESS glaucoma filtration device and implantables products including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery Its Vision Care segment provides daily disposable reusable and colorenhancing contact lenses ocular health products such as dry eye glaucoma contact lens care and ocular allergies and ocular vitamins and redness relievers under the TOTAL PRECISION DAILIES AquaComfort PLUS Air Optix OptiFree Clear Care Tears Naturale Genteal ICAPS and Vitalux brands The company was formerly known as Alcon Universal SA and changed the name to Alcon Inc in December 2001 Alcon Inc was founded in 1945 and is headquartered in Geneva Switzerland

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-02-24 $0.60 $0.62 -2.6%
2025-11-11 $0.63 $0.61 +2.9%

Financial Ratios (TTM)

Gross Margin
55.59%
Operating Margin
14.38%
Net Margin
10.70%
ROA
3.42%
Price to Book
1.90
Price to Sales
4.11